cancer-drug - Latest News on cancer-drug | Read Breaking News on Zee News

Supreme Court rejects Novartis cancer drug Glivec patent plea

Last Updated: Monday, April 01, 2013, 09:27

Glivec, used in treating chronic myeloid leukemia and some other cancers, costs a patient about Rs 1.2 lakh/month, much higher than Rs 8,000 which is the price of the generic drug.

Dr Reddy's Lab launches prostate cancer drug in India

Last Updated: Friday, December 07, 2012, 21:27

Drug firm Dr Reddy's Laboratories Friday said it has launched a cancer drug 'Pamorelin LA' in the country under an agreement with Switzerland-based Debiopharm Group.

Strides Arcolab gets USFDA approval for generic cancer drug

Last Updated: Thursday, November 29, 2012, 15:02

Strides Arcolab Thursday said its wholly-owned arm Onco Therapies has received approval from US health regulator for its generic version of cancer drug Ifosfamide.

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Friday, October 12, 2012, 17:39

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

Pfizer to challenge patent revocation of cancer drug Sutent

Last Updated: Friday, October 05, 2012, 17:42

The Indian Patents Office last month issued an order revoking Pfizer's patent of the drug in the country.

SC again asks Novartis to cut cancer drug price

Last Updated: Wednesday, September 12, 2012, 20:49

The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.

Novartis tells SC it has right to patent its cancer drug

Last Updated: Tuesday, September 11, 2012, 21:00

The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.

Novartis tells SC it has right to patent its cancer drug

Last Updated: Tuesday, September 11, 2012, 20:45

The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.

Strides Arcolab gets USFDA nod for cancer drug

Last Updated: Monday, September 03, 2012, 16:14

Drug firm Strides Arcolab Monday said its subsidiary has received American health regulator's approval to sell Vinorelbine injection, a cancer drug, in the American market.

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Sunday, September 02, 2012, 17:23

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

Cipla slashes cancer drug prices by up to 76%

Last Updated: Thursday, May 03, 2012, 20:37

Drug major Cipla on Thursday slashed the prices by up to 76 percent of its generic drugs, used in treating cancers of brain, lung and kidney.

Insight: Chasing cheaper cancer drugs

Last Updated: Monday, April 02, 2012, 09:24

In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.